May 4, 2009
UPDATE 2-Sequenom delays Down Syndrome test; shares plunge | uk.reuters.com
This delay is not good for the company, especially since there are already tests in place that are effective to screen for Down's syndrome. These tests now are the standard of care, so the longer it takes for Sequenon to launch it's test the worse, for the company.
Page : 11 to 1 of 1
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011